Weiskirch, L M <br/><br/>
Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  1991 
 - 353-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/BF01741330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Differentiation, T-Lymphocyte--physiology<br/>CD8 Antigens<br/>Cell Line<br/>Cytotoxicity, Immunologic--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Female<br/>In Vitro Techniques<br/>Ionomycin--pharmacology<br/>Lymphocyte Depletion<br/>Melphalan--therapeutic use<br/>Mice<br/>Mice, Inbred BALB C<br/>Phagocytes--physiology<br/>Plasmacytoma--drug therapy<br/>T-Lymphocytes--drug effects<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Thymoma--drug therapy<br/>Time Factors